Molecular Hydrogen as a Promising Therapy Could Be Linked With Increased Resting Treg Cells or Decreased Fas+ T Cell Subsets in a IgG4-PF-ILD Patient: A Case Report.

In Some patients do not respond to standard therapeutic interventions, on the fourth day of hydrogen-assisted therapy, a noticeable improvement in lung infiltrations was observed in chest X-rays as the patient gradually progressed towards weaning off mechanical ventilation.

Read More

Molecular Hydrogen as an Adjuvant Therapy in Comorbid Sjögren’s Syndrome, SLE, and ILD: A Case Report on Immune Modulation and Fatigue Reduction.

In They share features such as systemic inflammation and multi-organ involvement and typically require long-term immunosuppressive treatment, ongoing hydrogen therapy with high-dose vitamin C maintained disease stability and improved quality of life.

Read More